title: Universal neonatal audiological screening: experience of the University Hospital of Pisa.
abstract: The early identification of pre-lingual deafness is necessary to minimize the consequences of hearing impairment on the future communication skills of a baby. According to the most recent international guidelines the deafness diagnosis must occur before the age of three months and the prosthetic-rehabilitative treatment with a traditional hearing aid should start within the first six months. When a Cochlear implant becomes necessary, the treatment should start between the age of 12 months and 18 months. The only way to diagnose the problem early is the implementation of universal neonatal audiological screening programs. Transient evoked otoacoustic emissions (TEOAE) is the most adequate test because it's accurate, economic and of simple execution. Automatic auditory brainstem response (AABR) is necessary to identify patients with auditory neuropathy but it is also important to reduce the number of false-positives.The 20-30% of infant hearing impairment is represented by progressive or late-onset hearing loss (HL) so it's also necessary to establish an audiological follow up program, especially in infants at risk.From November 2005 all neonates born in the University hospital of Pisa undergo newborn hearing screening. From 2008 the screening program follows the guidelines for the execution of the audiological screening in Tuscany which have been formulated by our group according to the 2007 JCIH Position Statement and adaptated to our regional reality by a multidisciplinary effort. From November 2005 to April 2009 8113 neonates born in the Neonatal Unit of Santa Chiara Hospital (Pisa) have undergone newborn hearing screening. 7621 neonates (93.9%) without risk factors executed only the TEOAE test. 492 (6.1%) neonates had audiological risk factors and thus underwent TEOAE and AABR. 84 patients (1,04%) failed both TEOAE and AABR tests. 78 of them underwent further investigations. 44 patients resulted false positives (the 0,54% of the screened newborns). 34 neonates (4,2 ‰) had a final diagnosis of hearing impairment. 8 patients (0.99 ‰) had unilateral hearing loss (HL). 26 patients (3,2 ‰) had bilateral hearing impairment.In our screening program the percentage of false-positives was quite low (0.54%) while the incidence of bilateral HL (3.2 ‰) is a little higher than that found in literature reports. In most of our patients premature birth or neonatal suffering represent the main cause of HL.
authors.affiliation: Mother and Child Department, Neonatology Unit and Section of Neonatal Endocrinology and Dysmorphology, University Hospital of Pisa, Pisa, Italy. pghirri@med.unipi.it
authors.forename: Paolo
authors.initials: P
authors.lastname: Ghirri
authors.forename: Annalisa
authors.initials: A
authors.lastname: Liumbruno
authors.forename: Sara
authors.initials: S
authors.lastname: Lunardi
authors.forename: Francesca
authors.initials: F
authors.lastname: Forli
authors.forename: Antonio
authors.initials: A
authors.lastname: Boldrini
authors.forename: Angelo
authors.initials: A
authors.lastname: Baggiani
authors.forename: Stefano
authors.initials: S
authors.lastname: Berrettini
mesh_terms: D002985:Clinical Protocols; D015331:Cohort Studies; D003638:Deafness / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D006320:Hearing Tests; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007558:Italy; D008297:Male; D015997:Neonatal Screening; D011237:Predictive Value of Tests; D012189:Retrospective Studies